UBS Group’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-32,255
| Closed | -$31.8K | – | 9292 |
|
|
2025
Q1 | $31.8K | Buy |
32,255
+16,952
| +111% | +$16.7K | ﹤0.01% | 6604 |
|
|
2024
Q4 | $20K | Buy |
+15,303
| New | +$20K | ﹤0.01% | 6635 |
|
|
2024
Q2 | – | Sell |
-518
| Closed | -$2.44K | – | 8705 |
|
|
2024
Q1 | $2.44K | Buy |
518
+511
| +7,300% | +$2.41K | ﹤0.01% | 6728 |
|
|
2023
Q4 | $51 | Sell |
7
-1,848
| -100% | -$13.5K | ﹤0.01% | 7776 |
|
|
2023
Q3 | $22.4K | Sell |
1,855
-2,789
| -60% | -$33.7K | ﹤0.01% | 5608 |
|
|
2023
Q2 | $49.1K | Buy |
4,644
+2,466
| +113% | +$26.1K | ﹤0.01% | 5425 |
|
|
2023
Q1 | $21.4K | Sell |
2,178
-2,864
| -57% | -$28.2K | ﹤0.01% | 5942 |
|
|
2022
Q4 | $74.2K | Buy |
5,042
+1,491
| +42% | +$21.9K | ﹤0.01% | 5240 |
|
|
2022
Q3 | $43K | Buy |
3,551
+739
| +26% | +$8.95K | ﹤0.01% | 5427 |
|
|
2022
Q2 | $39K | Sell |
2,812
-532
| -16% | -$7.38K | ﹤0.01% | 5101 |
|
|
2022
Q1 | $48K | Sell |
3,344
-2,400
| -42% | -$34.5K | ﹤0.01% | 5516 |
|
|
2021
Q4 | $121K | Buy |
5,744
+2,092
| +57% | +$44.1K | ﹤0.01% | 5069 |
|
|
2021
Q3 | $96K | Sell |
3,652
-2,094
| -36% | -$55K | ﹤0.01% | 4783 |
|
|
2021
Q2 | $179K | Buy |
5,746
+4,332
| +306% | +$135K | ﹤0.01% | 4416 |
|
|
2021
Q1 | $43K | Buy |
1,414
+1,214
| +607% | +$36.9K | ﹤0.01% | 5694 |
|
|
2020
Q4 | $7K | Sell |
200
-464
| -70% | -$16.2K | ﹤0.01% | 6674 |
|
|
2020
Q3 | $20K | Buy |
+664
| New | +$20K | ﹤0.01% | 5446 |
|